Evidence map›Paper›PMID 36142735›Full record

ArticleInternational journal of molecular sciences2022

Mixture Effects of Tryptophan Intestinal Microbial Metabolites on Aryl Hydrocarbon Receptor Activity.

Aneta Vrzalová, Petra Pečinková, Peter Illés, Soňa Gurská, Petr Džubák, Martin Szotkowski, Marián Hajdúch, Sridhar Mani, Zdeněk Dvořák

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. ExploringBiomolecules & therapeutics · 2026
    Article
  4. Review
  5. Frontiers in pharmacology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Theranostics · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Chemistry towards Biology.International journal of molecular sciences · 2023
    Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Aneta VrzalováDepartment of Cell Biology and Genetics, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.ORCID 0000-0002-7923-5851
Petra PečinkováDepartment of Cell Biology and Genetics, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
Peter IllésDepartment of Cell Biology and Genetics, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.ORCID 0000-0003-3909-1491
Soňa GurskáInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900 Olomouc, Czech Republic.
Petr DžubákInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900 Olomouc, Czech Republic.ORCID 0000-0002-3098-5969
Martin SzotkowskiInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900 Olomouc, Czech Republic.
Marián HajdúchInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900 Olomouc, Czech Republic.ORCID 0000-0002-4834-908X
Sridhar ManiDepartment of Medicine, Molecular Pharmacology and Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.ORCID 0000-0003-4132-6157
Zdeněk DvořákDepartment of Cell Biology and Genetics, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.ORCID 0000-0002-3938-3585
Institute of Molecular and Translational Medicine · CZPalacký University Olomouc · CZAlbert Einstein College of Medicine · US

Funding

Czech Ministry of Education, Youth and Sports CZ-OPENSCREEN (LM2018130)Czech Ministry of Education, Youth and Sports EATRIS-CZ (LM2018133)Czech Science Foundation 20-00449SNational Institute for Cancer Research (Programme EXCELES, ID Project No. LX22NPO5102)the European Regional Development Fund ENOCH (No. CZ.02.1.01/0.0/0.0/16_019/0000868)
6 · The paper itself

Abstract

Aryl hydrocarbon receptor (AHR) plays pivotal roles in intestinal physiology and pathophysiology. Intestinal AHR is activated by numerous dietary, endogenous, and microbial ligands. Whereas the effects of individual compounds on AHR are mostly known, the effects of real physiological mixtures occurring in the intestine have not been studied. Using reporter gene assays and RT-PCR, we evaluated the combinatorial effects (3520 combinations) of 11 microbial catabolites of tryptophan (MICTs) on AHR. We robustly (n = 30) determined the potencies and relative efficacies of single MICTs. Synergistic effects of MICT binary mixtures were observed between low- or medium-efficacy agonists, in particular for combinations of indole-3-propionate and indole-3-lactate. Combinations comprising highly efficacious agonists such as indole-3-pyruvate displayed rather antagonist effects, caused by saturation of the assay response. These synergistic effects were confirmed by RT-PCR as CYP1A1 mRNA expression. We also tested mimic multicomponent and binary mixtures of MICTs, prepared based on the metabolomic analyses of human feces and colonoscopy aspirates, respectively. In this case, AHR responsiveness did not correlate with type of diet or health status, and the indole concentrations in the mixtures were determinative of gross AHR activity. Future systematic research on the synergistic activation of AHR by microbial metabolites and other ligands is needed.

Indexed as

Receptors, Aryl HydrocarbonTryptophanCytochrome P-450 CYP1A1HumansIndolesIntestinesLigandsPropionatesPyruvatesRNA, MessengerCytochrome P-450 CYP1A1IndolesLigandsPropionatesPyruvatesReceptors, Aryl HydrocarbonRNA, MessengerTryptophanaryl hydrocarbon receptorindole derivativesmicrobiomemimic mixturestryptophan metabolites

Identifiers

PMID36142735
PMCPMC9505659
OpenAlexW4296352690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.